[Aspirin tolerance in individuals with aspirin-induced urticaria-edematous lesions].
The study involved 22 individuals with aspirin-produced urticaria-edematous skin lesions. Hypersensitivity to aspirin was established with anamnesis showing such lesions on aspirin intake and oral test with aspirin. Threshold, provocative dose of aspirin was determined in all patients at the beginning of the study. Moreover, threshold provocative indomethacin dose was additionally determined in 12 patients. Tolerance to aspirin was produced by the oral administration of aspirin in increasing doses upto total dose 600 mg at a 24-hour intervals. Twelve patients were given 25 mg of indomethacin after 24 hours, and 50 mg of this drug after 48 hours. The patients tolerated indomethacin well during aspirin tolerance stage. The authors suggest that both urticaria-edematous and bronchial type of aspirin hypersensitivity are of the same pathogenetic origin.
Grzelewska-Rzymowska
I
I
Rozniecki
J
J
Szmidt
M
M
D000328:Adult; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects*; D003888:Desensitization, Immunologic; D003875:Drug Eruptions / Q000209:etiology*; D004487:Edema / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012130:Respiratory Hypersensitivity / Q000209:etiology; D014581:Urticaria / Q000139:chemically induced*
D001241:Aspirin
Tolerancja na aspiryne u osób z poaspirynowymi zmianami pokrzywkowo-obrzekowymi.